Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection
Boletín Médico del Hospital Infantil de México · 2024
DOI: 10.24875/bmhim.23000125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Boletín Médico del Hospital Infantil de México, 2024. Verfasst von José G Vázquez-Rosales und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Infectología. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis A Vaccines, Hepatitis A Antibodies, Hepatitis A.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
HIV-infected children have a higher risk of presenting infections, including the hepatitis A virus (HAV). The inactivated HAV vaccine is immunogenic in immunocompetent hosts; however, there are insufficient studies on the duration of seroprotection in HIV-infected children.
Methods
An analytical cohort study was conducted. HIV-1-infected children who received the inactivated HAV vaccine (2 doses) were included. Blood samples were taken for antibody measurement, the first one 28 days after the second dose and another 7 years after the vaccination schedule. Information on viral load, immunological category, weight, height, and response to antiretroviral treatment from diagnosis to the last assessment was obtained.
Results
19 patients were included, with a mean age of 12.6 years (SD ± 2.29). 58% were male. 80% of the patients presented protective immunoglobulin G antibodies against HAV 7-year post-vaccination. The antibody concentration was found to be between 13 and 80 mIU/mL (median of 80 mIU/mL). 52% showed some degree of immunosuppression. There was no statistically significant relationship between the presence of seroprotection and viral load, treatment failure, immunological category, and malnutrition. Twelve patients presented with antiretroviral treatment failure, and in 33% of them, the antibodies did not offer satisfactory seroprotection.
Conclusion
7-year post-vaccination, 80% of HIV-infected children maintain seroprotection titers against HAV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Infectología.
- Laboratorio de Virología. Unidad Médica de Alta Especialidad, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social.
- Unidad de Investigación en Enfermedades Infecciosas, Hospital Infantil de México "Federico Gómez." Mexico City, Mexico.
Zitieren
APA
Vázquez-Rosales, J. G., Melgoza-Salazar, A. P., G-Sámano-Aviña, M., Montaño-Luna, V. E., Lira-Carmona, M. R., & Solórzano-Santos, F. (2024). Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection. Boletín Médico del Hospital Infantil de México. https://doi.org/10.24875/bmhim.23000125
Vancouver
Vázquez-Rosales JG, Melgoza-Salazar AP, G-Sámano-Aviña M, Montaño-Luna VE, Lira-Carmona MR, Solórzano-Santos F. Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection. Boletín Médico del Hospital Infantil de México. 2024. doi:10.24875/bmhim.23000125
BibTeX
@article{VzquezRosales2024,
author = {Vázquez-Rosales, José G and Melgoza-Salazar, Alejandra P and G-Sámano-Aviña, Mariana and Montaño-Luna, Victoria E and Lira-Carmona, Ma Rosalía and Solórzano-Santos, Fortino},
title = {Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection},
journal = {Boletín Médico del Hospital Infantil de México},
year = {2024},
doi = {10.24875/bmhim.23000125}
}
EUVIMED